Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanoTinA-asthma: Tiotropium in Children with Moderate Persistent Asthma
NCT01634139Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Jul 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01634139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634139.